Signal2026-07-08
ClinicalTrials.gov

[EARLY_PHASE1] META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia

Part of

Early Phase Immune Therapeutics Trials

Open primary sourceSee the whole picture